Table 2.
Resident Cohort | Unadjusted | Adjusted | |||
---|---|---|---|---|---|
Characteristic or Risk Factor | Total (n = 230,730) | Nonfallers (n = 182,980) | Fallers (n = 47,750) | OR (95% Confidence Interval) | |
Time interval to follow-up assessment, mean ± SD | 62.9 ± 26.2 | 63.4 ± 25.6 | 61.0 ± 28.4 | ||
Age, mean ± SD | 78.9 ± 12.2 | 78.5 ± 12.4 | 80.5 ± 10.9 | 1.01 (1.01–1.01)a | 1.01 (1.01–1.01)a |
Female, % | 64.1 | 64.9 | 61.1 | 0.83 (0.81–0.85)a | 0.79 (0.77–0.81)a |
Race, % | |||||
White (reference) | 81.5 | 80.3 | 87.2 | ||
Black | 12.8 | 13.7 | 9.3 | 0.65 (0.63–0.67)a | 0.81 (0.78–0.84)a |
Hispanic | 4 | 4.3 | 3 | 0.72 (0.67–0.76)a | 0.80 (0.75–0.85)a |
Other | 1.7 | 1.7 | 1.5 | 0.86 (0.78–0.93)a | 0.92 (0.84–1.01) |
Medicare Part A, % | 70.6 | 70.2 | 72.2 | 1.09 (1.06–1.12)a | 1.00 (0.98–1.03) |
Fall history, % | 40.2 | 35.8 | 56.9 | 2.37 (2.32–2.42)a | 2.31 (2.26–2.37)a |
Comorbidity, % | |||||
Diabetes mellitus | 29.1 | 29.3 | 27.9 | 0.94 (0.92–0.97)a | 1.09 (1.06–1.12)a |
Cerebrovascular accident | 17.3 | 17 | 18.1 | 1.09 (1.06–1.12)a | 1.15 (1.12–1.19)a |
Parkinson's disease | 3.9 | 3.5 | 5.3 | 1.53 (1.46–1.61)a | 1.24 (1.18–1.31)a |
Cardiac dysrhythmia | 12.1 | 11.8 | 13.2 | 1.10 (1.06–1.13)a | 1.03 (1.00–1.07)a |
Congestive heart failure | 17.7 | 17.8 | 17.4 | 0.97 (0.94–0.99)a | 1.03 (1.00–1.06)a |
Hypertension | 53.5 | 53.6 | 53.8 | 0.99 (0.97–1.01) | 0.96 (0.94–0.98)a |
Hypotension | 1.1 | 1.1 | 1.3 | 1.16 (1.06–1.28)a | 1.04 (0.95–1.15) |
Arthritis | 19.7 | 19.7 | 19.9 | 0.98 (0.95–1.01) | 0.95 (0.92–0.98)a |
Osteoporosis | 11.2 | 11.2 | 11.5 | 1.00 (0.97–1.04) | 0.92 (0.90–0.96)a |
Hip fracture | 8.2 | 8 | 9.2 | 1.16 (1.12–1.20)a | 0.88 (0.84–0.92)a |
Alzheimer's disease | 11.9 | 11.5 | 13.8 | 1.21 (1.18–1.25)a | 1.01 (0.97–1.04) |
Dementia | 23.1 | 22.2 | 27.2 | 1.30 (1.27–1.33)a | 1.05 (1.02–1.07)a |
Depression | 26.8 | 26 | 29.8 | 1.20 (1.17–1.22)a | 1.05 (1.02–1.08)a |
Emphysema or chronic obstructive pulmonary disease | 15.5 | 15.7 | 15.1 | 0.95 (0.92–0.97)a | 0.97 (0.94–1.00)a |
Diabetic retinopathy | 0.4 | 0.4 | 0.4 | 0.87 (0.74–1.03) | 1.00 (0.84–1.19) |
Glaucoma | 4.5 | 4.4 | 4.5 | 1.01 (0.96–1.06) | 0.95 (0.90–1.00)a |
Macular degeneration | 2.7 | 2.6 | 3 | 1.11 (1.04–1.17)a | 1.00 (0.94–1.07) |
Cataracts | 2.6 | 2.6 | 2.7 | 1.00 (0.94–1.06) | 0.97 (0.90–1.03) |
Urinary tract infection | 18.6 | 18.5 | 18.9 | 1.02 (0.99–1.04) | 0.97 (0.94–1.00)a |
Urinary incontinence | 18.2 | 18.2 | 18.6 | 1.07 (1.04–1.10)a | 0.97 (0.94–1.00)a |
Symptoms in last 7 days, % | |||||
Dizziness | 1.6 | 1.4 | 2 | 1.22 (1.13–1.31)a | 1.09 (1.01–1.17)a |
Syncope | 0.6 | 0.4 | 0.9 | 1.40 (1.25–1.57)a | 1.09 (0.96–1.22) |
Medications | |||||
Number of medications, mean ± SD | 10.1 ± 4.6 | 10.1 ± 4.6 | 10.2 ± 4.5 | 1.00 (1.00–1.00)a | 1.01 (1.00–1.01)a |
Antipsychotic medication, % | 19.4 | 18.7 | 22.2 | 1.27 (1.24–1.30)a | 1.07 (1.04–1.10)a |
Anti-anxiety medication, % | 16.7 | 15.6 | 20.3 | 1.37 (1.34–1.41)a | 1.26 (1.22–1.29)a |
Antidepressant, % | 32.7 | 31.7 | 36.8 | 1.24 (1.22–1.27)a | 1.18 (1.15–1.22)a |
Diuretic, % | 31.3 | 31.5 | 30.3 | 0.93 (0.91–0.95)a | 0.97 (0.94–0.99)a |
Hypnotic, % | 8.5 | 8.4 | 8.9 | 1.07 (1.03–1.10)a | 1.07 (1.03–1.11)a |
Daily pain, % | 20.1 | 20.4 | 18.9 | 0.88 (0.86–0.91)a | 0.95 (0.92–0.97)a |
Cognitive Performance Scale score, % | |||||
0–2 (low) (reference) | 54.6 | 56.8 | 46.4 | ||
3–4 (moderate) | 36.6 | 34.6 | 44.2 | 1.59 (1.56–1.63)a | 1.38 (1.35–1.42)a |
5–6 (high) | 8.8 | 8.6 | 9.4 | 1.37 (1.32–1.42)a | 1.35 (1.29–1.41)a |
Wandering in last 7 days, % | 9 | 8.2 | 12.1 | 1.53 (1.48–1.58)a | 1.28 (1.24–1.33)a |
Body mass index, kg/m2, % | |||||
<18.5 | 10.6 | 10.5 | 0.99 (0.96–1.03) | 1.05 (1.01–1.08)a | |
18.5–30.0 (reference) | 70.6 | 69.7 | 74 | ||
>30.0 | 18.8 | 19.8 | 15.1 | 0.71 (0.69–0.73)a | 0.83 (0.81–0.86)a |
ADL (range 0–28), mean ± SD | 16.3 ± 6.9 | 16.3 ± 7.1 | 16.6 ± 6.2 | 1.01 (1.01–1.01)a | 1.00 (1.00–1.00) |
Impaired balance, % | 91.9 | 91.3 | 94.2 | 1.52 (1.46–1.59)a | 1.33 (1.27–1.40)a |
Bedbound, % | 3.5 | 3.9 | 2.1 | 0.53 (0.50–0.57)a | 0.66 (0.62–0.71)a |
Uses a cane, crutch, walker, % | 33.3 | 32.2 | 37.8 | 1.27 (1.24–1.29)a | 1.20 (1.17–1.23)a |
Range of motion, % | |||||
Limited in lower extremity | 30.2 | 30.9 | 27.8 | 0.86 (0.84–0.88)a | 0.88 (0.86–0.91)a |
Limited in feet | 19.8 | 20.6 | 16.9 | 0.78 (0.76–0.80)a | 0.93 (0.90–0.96)a |
Restraints used daily in last 7 days, % | 1.3 | 1.2 | 1.8 | 1.57 (1.44–1.70)a | 1.04 (0.96–1.13) |
Interpretation of continuous variables odds ratios (ORs): medication (adjusted model), for each additional medication per day there is a 1% increasein odds of a fall; activity of daily living (ADL) status in the unadjusted model can be interpreted as each additional unit increase in ADL score was associated with a 1% increase in odds of a fall.
SD=standard deviation.
P < .05.